由HCC衍生的miR-17-5p的外体转移通过准RUNX1-NKG2D轴来降低NK细胞的功能
Zhifeng Zhou1, Tianchuan Li2, Jieyu Li1
1Laboratory of Immuno-Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; School of Basic Medical Sciences, Fujian Medical University, Fuzhu, Fujian, China.
International immunopharmacology
|May 31, 2024
概括
肝细胞癌 (HCC) 外基因组含有miR-17-5p,该外基因组针对RUNX1.1. 这种相互作用抑制了NK细胞对HCC的活性,阻碍了抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 自然杀手 (NK) 细胞对于瘤微环境中的抗瘤免疫是至关重要的.
- 微RNAs (miRNAs) 调节基因表达,并影响NK细胞的发育和功能.
- 肝细胞癌 (HCC) 构成了重大的健康挑战,需要新的治疗策略.
研究的目的:
- 调查miR-17-5p在HCC外体中调节NK细胞细胞毒性的作用.
- 阐明涉及转录因子RUNX1和NKG2D的分子机制.
主要方法:
- 从HCC组织和细胞系中分离出外体.
- 使用miRNA分析,qRT-PCR和西式斑点检测进行验证.
- 路西法酶记者测定,ChIP和体外/体内测试评估了分子相互作用和细胞功能.
主要成果:
- 在HCC外基因组中,miR-17-5p水平升高.
- miR-17-5p直接准RUNX1,它可以积极调节NKG2D转录.
- 通过miR-17-5p降低RUNX1和NKG2D的调节,损害了NK细胞杀死HC细胞的功能.
结论:
- 在HCC外体内,miR-17-5p通过准RUNX1.1,抑制NK细胞介导的抗瘤活性.
- 这种机制突显出一种新的免疫逃避途径在HCC.
- 针对miR-17-5p或其下游效应器可能代表HCC的治疗方法.
更多相关视频
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
734
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
384
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:27Cytotoxic T Cells-mediated Immune Response
891
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
891